Escolar Documentos
Profissional Documentos
Cultura Documentos
Abstract
Bristol-Meyers Squibb is one of the largest pharmaceutical companies in the world, with 28,000
employees and $15.9 billion in sales in 2014. As a leading pharmaceutical company, it has face a lot
of challenges and obstacles since its establishment in 1989. BMS, like the rest of the
pharmaceutical industry, is facing major challenges in the business environment. Some of these
include greater restrictions on access to physicians, increased pricing pressures from
governments and stricter regulatory guidelines.BMS launched a Productivity Transformation
initiative to enhance its competitiveness in order to address these challenges. The mission of the
organization is to provide innovative, high impact, cost effective learning solutions that meets the
business need.
biopharmaceutical company that discovers and delivers medicine and it has to face stiff
competition from competitors or risk going back out of the business due to several reasons. The
leading and largest product of BMS, Plavix which is use for treatment of hypertension and
diabetic, faces a patent expiration. It is very difficult for BMS to be on par with the rest of its
competitors in the industry due to the continuing rise of its R&D costs apart from facing a rigid
competition from generic drug makers
Vision Statement
According to the case study, BMS does not publicly have available vision statement. After
detailed discussion and research, the researcher has decided to propose and effective vision
statement for BMS company that fits its image as one of the big dogs in the pharmaceutical
business.
Proposed
To make continuous improvement on producing an excellent pipeline of drugs and put greater
effort on fulfilling demand on serious unmet medical needs. We take a pledge to become a leader
in pharmaceutical industry while continue improving our drugs for the benefits off all
stakeholders.
Mission statement
To discover, develop and deliver innovative medicines that help patients prevail over serious
disease. BMS has more lengthy commitment statement as follows to our patients and